📊 Score Breakdown
Offering Ability
90
Cash Runway
95
Float Risk
22
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
68%
💰 Capital Raise
75%
• Critical: only 1.7 months cash remaining
• Active shelf registration ($100M, 613% of market cap)
🔄 Reverse Split
70%
• 50-day avg $0.73 below $1 exchange minimum
• Only 2 months cash — financial pressure
📉 Score Deterioration
50%
• Score rose 46 points recently (worsening)
• Score in HIGH risk zone (67/100)
💹 Market Data
Market Cap$16.32M
Shares Outstanding20.19M
Float14.20M
Cash$295.8K
Debt$12.2K
Short InterestN/A
🏛 Institutional Holdings
8 institutional holders · 241.7K shares
#1
Citadel Advisors Llc
122.4K shares
#2
DRW Securities, LLC
45.3K shares
#3
Blackrock Inc.
29.4K shares
+ 5 more holders Sign up free to view →
📉 Short Interest
Short Interest168.7K
Days to Cover1.0
% of Float1.2%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Apr 30, 2024
EFFECT
EFFECT
Apr 17, 2026
S-3
SHELF
Apr 03, 2026
13F-HR
BENEFICIAL OWNERSHIP
Dec 31, 2025
13F-HR
BENEFICIAL OWNERSHIP
Dec 31, 2025
Full SEC filing analysis available with free account →
📰 Recent News
🔬 More Research for MWYN
📊 MWYN FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 MWYN Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.